(CercleFinance.com) – Nanobiotix announces the closing by Johnson & Johnson Innovation (JJDC) of the previously announced subscription for 901,256 additional ordinary shares, in the form of ADSs, for a total amount of $4.8 million, or 4 .6 million euros.
This investment follows the French Ministry of Economy’s approval of JJDC’s remaining investment on November 22, in accordance with rules governing the control of foreign investments in France.
The total gross proceeds of approximately 50.9 million euros received by Nanobiotix thus increased to approximately 55.5 million, extending the financial visibility of the biotechnology company until mid-2025.